Journal of Molecular and Cellular Cardiology
Volume 46, Issue 3 , Pages 395-404 , March 2009

CELF-mediated alternative splicing is required for cardiac function during early, but not later, postnatal life

  • Fulvia Terenzi

      Affiliations

    • Department of Cell Biology, Lerner Research Institute, Cleveland Clinic Foundation, 9500 Euclid Ave. NC10, Cleveland, OH 44195, USA
  • ,
  • Kyle R. Brimacombe

      Affiliations

    • Department of Cell Biology, Lerner Research Institute, Cleveland Clinic Foundation, 9500 Euclid Ave. NC10, Cleveland, OH 44195, USA
  • ,
  • Marc S. Penn

      Affiliations

    • Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, OH 44195, USA
    • Department of Stem Cell Biology and Regenerative Medicine, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH 44195, USA
  • ,
  • Andrea N. Ladd

      Affiliations

    • Department of Cell Biology, Lerner Research Institute, Cleveland Clinic Foundation, 9500 Euclid Ave. NC10, Cleveland, OH 44195, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 216 445 3870; fax: +1 216 444 9404.

Received 22 August 2008 ,Revised 11 October 2008 ,Accepted 30 October 2008.

References 

  1. MacLellan WR, Schneider MD. Genetic dissection of cardiac growth control pathways. Annu. Rev. Physiol. 2000;62:289–319
  2. Chen HW, Yu SL, Chen WJ, Yang PC, Chien CT, Chou HY, et al. Dynamic changes of gene expression profiles during postnatal development of the heart in mice. Heart. 2004;90:927–934
  3. Siedner S, Kruger M, Schroeter M, Metzler D, Roell W, Fleischmann BK, et al. Developmental changes in contractility and sarcomeric proteins from the early embryonic to the adult stage in the mouse heart. J. Physiol. 2003;548:493–505
  4. Harrell MD, Harbi S, Hoffman JF, Zavadil J, Coetzee WA. Large-scale analysis of ion channel gene expression in the mouse heart during perinatal development. Physiol. Genomics. 2007;28:273–283
  5. Johnson J, Castle J, Garrett-Engele P, Kan Z, Loerch P, Armour C, et al. Genome-wide survey of human alternative pre-mRNA splicing with exon junction microarrays. Science. 2003;302:2141–2144
  6. Xu X, Fu XD. Conditional knockout mice to study alternative splicing in vivo. Methods. 2005;37:387–392
  7. Cooper T, Ordahl C. A single cardiac troponin T gene generates embryonic and adult isoforms via developmentally regulated alternate splicing. J. Biol. Chem. 1985;260:11140–11148
  8. McAuliffe J. Delineation of the cardiac troponin T expression pattern during murine development. J. Cell. Biochem. 1994;18D(suppl):W347
  9. Townsend P, Barton P, Yacoub M, Farza H. Molecular cloning of human cardiac troponin T isoforms: expression in developing and failing heart. J. Mol. Cell. Cardiol. 1995;27:2223–2236
  10. Godt R, Fogaca R, Silva I, Nosek T. Contraction of developing avian heart muscle. Comp. Biochem. Physiol. [A]. 1993;105:213–218
  11. McAuliffe J, Gao L, Solaro R. Changes in myofibrillar activation and troponin C Ca2+ binding associated with troponin T isoform switching in developing rabbit heart. Circ. Res. 1990;66:1204–1216
  12. Gomes AV, Guzman G, Zhao J, Potter JD. Cardiac troponin T isoforms affect the Ca2+ sensitivity and inhibition of force development. Insights into the role of troponin T isoforms in the heart. J. Biol. Chem. 2002;277:35341–35349
  13. Ding JH, Xu X, Yang D, Chu PH, Dalton N, Ye Z, et al. Dilated cardiomyopathy caused by tissue-specific ablation of SC35 in heart. EMBO J. 2004;23:885–896
  14. Ladd A, Charlet-B N, Cooper T. The CELF family of RNA binding proteins is implicated in cell-specific and developmentally regulated alternative splicing. Mol. Cell. Biol. 2001;21:1285–1296
  15. Ladd A, Stenberg M, Swanson M, Cooper T. A dynamic balance between activation and repression regulates pre-mRNA alternative splicing during heart development. Dev. Dyn. 2005;233:783–793
  16. Ladd A, Taffet G, Hartley C, Kearney D, Cooper T. Cardiac-specific repression of CELF activity disrupts alternative splicing and causes cardiomyopathy. Mol. Cell. Biol. 2005;25:6267–6278
  17. Hartley C, Taffet G, Reddy A, Entman M, Michael L. Noninvasive cardiovascular phenotyping in mice. ILAR J. 2002;43:147–158
  18. Lyons G, Schiaffino S, Sassoon D, Barton P, Buckingham M. Developmental regulation of myosin gene expression in mouse cardiac muscle. J. Cell Biol. 1990;111:2427–2436
  19. Ladd A, Nguyen N, Malhotra K, Cooper T. CELF6, a member of the CELF family of RNA binding proteins, regulates muscle-specific splicing enhancer-dependent alternative splicing. J. Biol. Chem. 2004;279:17756–17764
  20. Choi D, Ito T, Tsukahara F, Hirai M, Sakaki Y. Developmentally regulated expression of mNapor encoding an apoptosis-induced ELAV-type RNA binding protein. Gene. 1999;237:135–142
  21. Lu X, Timchenko N, Timchenko L. Cardiac elav-type RNA-binding protein (ETR-3) binds to RNA CUG repeats expanded in myotonic dystrophy. Hum. Mol. Gen. 1999;8:53–60
  22. Good P, Chen Q, Warner S, Herring D. A family of human RNA-binding proteins related to the Drosophila Bruno translational regulator. J. Biol. Chem. 2000;275:28583–28592
  23. Li D, Bachinski L, Roberts R. Genomic organization and isoform-specific tissue expression of human NAPOR (CUGBP2) as a candidate gene for familial arrhythmogenic right ventricular dysplasia. Genomics. 2001;74:396–401
  24. Loria P, Duke A, Rand J, Hobert O. Two neuronal, nuclear-localized RNA binding proteins involved in synaptic transmission. Curr. Biol. 2003;13:1317–1323
  25. Meins M, Schlickum S, Wilhelm C, Missbach J, Yadav S, Glaser B, et al. Identification and characterization of murine Brunol4, a new member of the elav/bruno family. Cytogenet. Genome Res. 2002;97:254–260
  26. Brimacombe K, Ladd A. Cloning and embryonic expression patterns of the chicken CELF family. Dev. Dyn. 2007;236:2216–2224
  27. Ho T, Charlet-B N, Poulos M, Singh G, Swanson M, Cooper T. Muscleblind proteins regulate alternative splicing. EMBO J. 2004;23:3103–3112
  28. Fardaei M, Rogers M, Thorpe H, Larkin K, Hamshere M, Harper P, et al. Three proteins, MBNL, MBLL and MBXL, co-localize in vivo with nuclear foci of expanded-repeat transcripts in DM1 and DM2 cells. Hum. Mol. Gen. 2002;11:805–814
  29. Kanadia RN, Urbinati CR, Crusselle VJ, Luo D, Lee YJ, Harrison JK, et al. Developmental expression of mouse muscleblind genes Mbnl1, Mbnl2 and Mbnl3. Gene Expr. Patterns. 2003;3:459–462
  30. Kress C, Gautier-Courteille C, Osborne HB, Babinet C, Paillard L. Inactivation of CUG-BP1/CELF1 causes growth, viability, and spermatogenesis defects in mice. Mol. Cell. Biol. 2007;27:1146–1157
  31. Timchenko N, Iakova P, Cai ZJ, Smith J, Timchenko L. Molecular basis for impaired muscle differentiation in myotonic dystrophy. Mol. Cell. Biol. 2001;21:6927–6938
  32. Mukhopadhyay D, Houchen C, Kennedy S, Dieckgraefe B, Anant S. Coupled mRNA stabilization and translational silencing of cyclooxygenase-2 by a novel RNA binding protein, CUGBP2. Mol. Cell. 2003;11:113–126
  33. Paillard L, Legagneux V, Osborne H. A functional deadenylation assay identifies human CUG-BP as a deadenylation factor. Biol. Cell. 2003;95:107–113
  34. Gao Z, Xu H, DiSilvestre D, Halperin VL, Tunin R, Tian Y, et al. Transcriptomic profiling of the canine tachycardia-induced heart failure model: global comparison to human and murine heart failure. J. Mol. Cell. Cardiol. 2006;40:76–86
  35. Lowes BD, Zolty R, Shakar SF, Brieke A, Gray N, Reed M, et al. Assist devices fail to reverse patterns of fetal gene expression despite beta-blockers. J. Heart Lung Transplant. 2007;26:1170–1176
  36. Kuyumcu-Martinez NM, Cooper TA. Misregulation of alternative splicing causes pathogenesis in myotonic dystrophy. Prog. Mol. Subcell. Biol. 2006;44:133–159
  37. Wheeler TM, Lueck JD, Swanson MS, Dirksen RT, Thornton CA. Correction of ClC-1 splicing eliminates chloride channelopathy and myotonia in mouse models of myotonic dystrophy. J. Clin. Invest. 2007;117:3952–3957

PII: S0022-2828(08)01400-4

doi: 10.1016/j.yjmcc.2008.10.030

Journal of Molecular and Cellular Cardiology
Volume 46, Issue 3 , Pages 395-404 , March 2009